✦ LIBER ✦

Design and Rationale of the PROTECT Study: A Placebo-controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function

✍ Scribed by Beth Davison Weatherley; Gad Cotter; Howard C. Dittrich; Paul DeLucca; George A. Mansoor; Daniel M. Bloomfield; Piotr Ponikowski; Christopher M. O'Connor; Marco Metra; Barry M. Massie

Book ID: 116339908
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 217 KB
Volume: 16
Category: Article
ISSN: 1532-8414
DOI: 10.1016/j.cardfail.2009.10.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of Rolofylline, a Selective Adeno

Effect of Rolofylline, a Selective Adenosine A1 Receptor Antagonist, in Patients Hospitalized for Acute Decompensated Heart Failure and Renal Impairment: Findings from the PROTECT Study

✍ M. Christopher O'Connor 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 100 KB

The PROTECT Pilot Study: A Randomized, P

The PROTECT Pilot Study: A Randomized, Placebo-Controlled, Dose-Finding Study of the Adenosine A1 Receptor Antagonist Rolofylline in Patients With Acute Heart Failure and Renal Impairment

✍ Gad Cotter; Howard C. Dittrich; Beth Davison Weatherley; Daniel M. Bloomfield; C 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 396 KB

Effects of the Adenosine A1 Receptor Ant

Effects of the Adenosine A1 Receptor Antagonist, KW-3902, Alone and in Combination with Furosemide, on Diuresis and Renal Function in Hospitalized Acutely Decompensated Heart Failure Patients with Renal Impairment: A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study

✍ Howard C. Dittrich; Michael Tansey; Gadi Cotter; Tara K. Fields; Leeanne L. Pear 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Effect of the Adenosine A1 Receptor Anta

Effect of the Adenosine A1 Receptor Antagonist, KW-3902, on Diuresis and Renal Function in Patients with Acute Decompensated Heart Failure Refractory to Maximum Doses of Conventional Diuretics: A Randomized, Double-Blind, Placebo Controlled, Dose Escalation Study

✍ Michael M. Givertz; Michael Tansey; Leeanne L. Pearson; Tara K. Fields; Howard C 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Rationale and study design for a multice

Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure

✍ Mihai Gheorghiade; Wendy A. Gattis; Alejandro Barbagelata; Kirkwood F. Adams Jr; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Rationale, design, and results from RENO

Rationale, design, and results from RENO-DEFEND 1: A randomized, dose-finding study of the selective A1 adenosine antagonist SLV320 in patients hospitalized with acute heart failure

✍ Peter S. Pang; Mandeep Mehra; Aldo P. Maggioni; Gerasimos Filippatos; Jayne Midd 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 278 KB